Clinical Trial Update: POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

View source ↗

Summary

This is a clinical cohort study at University Medical Center Groningen evaluating patients with melanoma and non-small cell lung cancer who are receiving checkp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Checkpoint inhibitors (immune checkpoint inhibitors (PD-1/PD-L1/CTLA-4 inhibitors))

Snippet

Sponsor: University Medical Center Groningen | Conditions: Melanoma, Non-Small Cell Lung Cancer | Status: RECRUITING